Kyongbo Pharmaceutical
경보제약KRX: 214390· Fiscal year 2025· kbpharma.co.kr ↗
Average salary
$56.0K
₩74.6M
▲ 3.9% vs 2024
Employees
571
▲ 8.8% vs 2024
Average tenure
Not disclosed
Estimated take-home of this pay:$3.8K / monthCalculate →
Workplace
Women's pay (men = 100)78
Women among staff23.3%
Contract staff2.3%
Recent official filings
- 2026-11-16Quarterly report (2026.09)
- 2026-10-30Preliminary earnings
- 2026-08-14Half-year report (2026.06)
- 2026-07-31Preliminary earnings
Quick read
- Average pay is 22% above the median of the companies we track.
- Average pay rose 3.9% from 2024.
- Headcount grew by 46 (8.8%) from 2024.
- Ranks #35 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 10.7% year over year.
- Revenue has grown two years in a row.
- Operating margin was 1.3% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $346.3K
- Net profit per employee
- $239
- Operating margin
- 1.3%
- Net margin
- 0.1%
- ROE
- 0.1%
- Debt-to-equity
- 119.3%
- Equity ratio
- 45.6%
- Payout ratio
- 656.6%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 0.8%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.